ERIS (ERIS) News
Follow ERIS (ERIS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ChrysCap, Tata Cap Fund III Invest $70m in Linux Labs
Tata Capital Healthcare Fund II MAKES COMPLETE EXIT Our Bureau Mumbai: Drug maker Linux Laboratories said on Tuesday that it secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. C
MNA | Sep 30, 2026, 04:17 AM UTC
L
Eris, Torrent Pharma, Natco, Lupin stand out in Rs157 billion India GLP-1 opportunity: Kotak
Eris Lifesciences, Torrent Pharma, Natco Pharma and Lupin are expected to see the highest contribution to FY2029E earnings per share from India's GLP-1 opportunity, at 4-12%, according to Kotak Institutional Equities. Su
EARNINGS | Sep 10, 2026, 05:41 AM UTC